| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 02/28/2007 | CN1922146A Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921837A Method of preparing low-crystallinity oltipraz or amorphous oltipraz |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301970C 2,4-substituted indoles and their use as 5-HT6 modulators |
| 02/27/2007 | US7183419 Reacting a 2,5-di(alkoxycarbonyl)-3,4-dihydroxythiophene or the alkali metal salt thereof with a ditosylate and cleaving the ester and decarboxylating the intermediate thus formed; used as monomers for pi-conjugated polymers |
| 02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
| 02/27/2007 | US7183413 Aminoquinoline compounds |
| 02/27/2007 | US7183411 Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183312 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 02/27/2007 | US7183305 Reaction of cyano compound with silylalkylisocyanide for active imidazoles |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/22/2007 | WO2007022258A1 Novel high affinity thiophene-based and furan-based kinase ligands |
| 02/22/2007 | WO2007021794A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | WO2007020190A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | WO2007020098A1 Method for producing substituted pyrazoles |
| 02/22/2007 | WO2007020046A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 02/22/2007 | WO2007019933A1 1-acyldihydropyrazol derivatives |
| 02/22/2007 | WO2006134163A8 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 02/22/2007 | US20070043222 2,6-bis(2,2'-bithiopheny1)-1,4-dithiin as charge transporting organic material; good processing properties, thin film obtained has high charge-transporting characteristics; as protective films for capacitor electrodes, antistatic films, solar cells or fuel cells. |
| 02/22/2007 | US20070043081 N-Cyclopropyl-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-2-fluoro-benzenesulfonamide; 2-(4-Chloro-phenyl)-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-N-methyl-acetamide; neurohormonal antagonists |
| 02/22/2007 | US20070043080 Substituted anilinic piperidines as MCH selective antagonists |
| 02/22/2007 | US20070043051 Methods and compositions of novel triazine compounds |
| 02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 02/22/2007 | US20070043045 Novel high affinity thiophene-based and furan-based kinase ligands |
| 02/22/2007 | US20070043043 Benzimidazole derivates: preparation and pharmaceutical applications |
| 02/22/2007 | US20070043041 Indol-6 sulfonamide derivative, their preparation and their use 5-ht-6 as modulators |
| 02/22/2007 | US20070043040 Inhibitors of akt (protein kinase b) |
| 02/22/2007 | US20070043037 Pyrimidine derivatives as orexin receptor antagonists |
| 02/22/2007 | US20070043011 Substituted benzanilide compound and noxious organism controlling agent |
| 02/22/2007 | US20070043010 Quinazoline derivatives |
| 02/22/2007 | CA2619790A1 Novel high affinity thiophene-based and furan-based kinase ligands |
| 02/22/2007 | CA2619780A1 Method for producing substituted parasols |
| 02/22/2007 | CA2619706A1 Novel high affinity quinoline-based kinase ligands |
| 02/22/2007 | CA2619249A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 02/22/2007 | CA2619223A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | CA2619039A1 1-acyldihydropyrazole derivatives |
| 02/22/2007 | CA2618747A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1753758A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/21/2007 | EP1753750A1 Thiophene heteroaryl amines |
| 02/21/2007 | EP1753749A1 Novel indole derivatives as selective androgen receptor modulators (sarms) |
| 02/21/2007 | EP1753743A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals |
| 02/21/2007 | EP1753735A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| 02/21/2007 | EP1753725A1 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 02/21/2007 | EP1753721A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 02/21/2007 | EP1753719A1 Substituted pyrrolidine-2-ones |
| 02/21/2007 | EP1753718A1 3-amino-2-phenylpyrrolidine derivatives |
| 02/21/2007 | EP1581517B1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/21/2007 | EP1567488B1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | CN1918152A C10 cyclopentyl ester substituted taxanes |
| 02/21/2007 | CN1918147A 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 02/21/2007 | CN1918141A Aminodibenzodioxin derivative and organic electroluminescent device using same |
| 02/21/2007 | CN1918135A Aminoquinoxaline compound, polyaminoquinoxaline compound, and use thereof |
| 02/21/2007 | CN1918129A Therapeutic agent |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | CA2186784C The use of carboxylic acid derivatives as drugs |
| 02/20/2007 | CA2180156C Self-assembled taxo-diperpenoid nanostructures |
| 02/20/2007 | CA2085192C Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones |
| 02/15/2007 | WO2007018941A2 Pyrimidyl-thiophene derivatives |
| 02/15/2007 | WO2007018439A1 Conducting polymers and uses thereof |
| 02/15/2007 | WO2007018319A1 Pyridylphenol compound and use thereof |
| 02/15/2007 | WO2007017670A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
| 02/15/2007 | WO2007017114A1 New substituted azathymidine derivatives and their use in the treatment of bacterial infectious diseases |
| 02/15/2007 | WO2007017096A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/15/2007 | WO2007016784A1 Novel substituted 1,2,3-tπazolylmethyl-benzothiophene or -indole and their use as leukotπene biosynthesis inhibitors |
| 02/15/2007 | WO2006136829A3 Pyrazole derivatives and their use as pka and pkb modulators |
| 02/15/2007 | WO2006081337A3 Erastin analogues and their uses for killing cancer cells |
| 02/15/2007 | US20070037984 Biphenyl derivatives |
| 02/15/2007 | US20070037858 Hexyl carboxanilides and their use for controlling undesirable micro-organisms |
| 02/15/2007 | US20070037853 N-(3-aminopropyl)-N-{1-[1-benzyl-4-(3-chlorophenyl)-1H-imidazol-2-yl]-2-methylpropyl}morpholine-4-carboxamide and derivatives; kinesin spindle protein (KSP) inhibitors; anticarcinogenic agents; antimiotic; gene expression inhibition |
| 02/15/2007 | US20070037839 useful in Pharmaceutical medicines or pharmacological tools; cytostatic agents; antiproliferative/antineoplastic agents; 2-Anilino-4-[1-isopropyl-2-(hydroxyiminomethyl)imidazol-5-yl]pyrimidine; rheumatoid arthritis; breast cancer |
| 02/15/2007 | US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide |
| 02/15/2007 | US20070037819 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine |
| 02/15/2007 | US20070037807 Pyridine compounds as inhibitors of dipeptidyl peptidase IV |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070037012 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle |
| 02/15/2007 | CA2618888A1 Acyltryptophanols for fertility control |
| 02/15/2007 | CA2618586A1 Novel substituted 1,2,3-triazolylmethyl-benzothiophene or -indole and their use as leukotriene biosynthesis inhibitors |
| 02/15/2007 | CA2618474A1 Compounds for treating alzheimer's disease |